Fringe gene
Fringe gene refers to a family of genes in humans and other organisms that play a crucial role in the regulation of the Notch signaling pathway, a highly conserved cell signaling system that influences cell fate determination, differentiation, proliferation, and apoptosis. The fringe gene family includes several members, such as Lunatic fringe (LFNG), Manic fringe (MFNG), and Radical fringe (RFNG), each encoding for glycosyltransferase enzymes that modify Notch receptors and alter their ability to respond to ligands.
Function[edit]
The primary function of the fringe genes is to modulate the Notch signaling pathway, which is pivotal in various developmental processes and in the maintenance of adult tissue homeostasis. By adding N-acetylglucosamine to O-fucose residues on the Notch receptor, fringe gene products can enhance or inhibit the interaction between Notch and its ligands, Delta and Jagged. This modification is crucial for the spatial and temporal regulation of Notch signaling, affecting processes such as somite segmentation, neurogenesis, and angiogenesis.
Genetic Regulation[edit]
The expression of fringe genes is tightly regulated and varies spatially and temporally during development. Transcription factors, signaling molecules, and epigenetic modifications influence the expression of LFNG, MFNG, and RFNG, ensuring that Notch signaling is modulated appropriately in different cellular contexts.
Clinical Significance[edit]
Alterations in the expression or function of fringe genes have been implicated in a variety of human diseases. For example, mutations in LFNG are associated with spondylocostal dysostosis, a congenital disorder characterized by vertebral and rib malformations. Furthermore, aberrant fringe gene activity has been observed in several types of cancer, where it can promote tumor growth and progression by dysregulating Notch signaling.
Research Directions[edit]
Ongoing research aims to further elucidate the mechanisms by which fringe genes regulate Notch signaling and to understand their roles in development and disease. Additionally, fringe genes are being explored as potential therapeutic targets. Modulating their activity could offer new strategies for treating diseases associated with Notch signaling dysregulation, including certain cancers and genetic disorders.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
